Abstract |
1. The effect of the tachykinin neurokinin1 (NK1) receptor antagonist GR203040 on cyclophosphamide (CYP)-induced bladder damage was investigated in rats and ferrets. The 5-hydroxytryptamine3 receptor antagonists ondansetron and granisetron were similarly examined in ferrets. 2. In the rat, GR203040 (10 and 30 mg/kg i.p.) reduced the CYP-induced plasma protein extravasation in the bladder by 44% and 73%, respectively (P < 0.05 and 0.005; cf. CYP controls); in the ferret, a 57% reduction (P < 0.005) was observed after GR203040 (0.3 mg/kg SC). No decrease was observed in ferrets with either ondansetron or granisetron (1 mg/kg SC). 3. GR203040 attenuated the CYP-induced damage in the rat and ferret bladder, at the same dose in the ferret previously shown to inhibit CYP-induced emesis.
|
Authors | A Alfieri, C Gardner |
Journal | General pharmacology
(Gen Pharmacol)
Vol. 29
Issue 2
Pg. 245-50
(Aug 1997)
ISSN: 0306-3623 [Print] England |
PMID | 9251907
(Publication Type: Journal Article)
|
Chemical References |
- Blood Proteins
- Neurokinin-1 Receptor Antagonists
- Piperidines
- Tetrazoles
- (2-methoxy-5-tetrazol-1-ylbenzyl)(2-phenylpiperidin-3-yl)amine
- Cyclophosphamide
|
Topics |
- Animals
- Blood Proteins
(metabolism)
- Cyclophosphamide
(antagonists & inhibitors, toxicity)
- Ferrets
- Male
- Neurokinin-1 Receptor Antagonists
- Piperidines
(pharmacology)
- Rats
- Rats, Wistar
- Tetrazoles
(pharmacology)
- Urinary Bladder
(anatomy & histology, drug effects)
|